(Q42513522)

1 November 2017

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer (English)

1 reference

1 November 2017

1 reference

Jochen Gaedcke

1

1 reference

1 November 2017

Frank Traub

2

1 reference

1 November 2017

Simone Milde

3

1 reference

1 November 2017

Ludwig Wilkens

4

1 reference

1 November 2017

Alexandru Stan

5

1 reference

1 November 2017

Helmut Ostertag

6

1 reference

1 November 2017

Mathias Christgen

7

1 reference

1 November 2017

Reinhard von Wasielewski

8

1 reference

1 November 2017

Hans H Kreipe

9

1 reference

1 November 2017

language of work or name

1 reference

1 June 2007

1 reference

1 November 2017

1 reference

1 November 2017

20

1 reference

1 November 2017

864-870

1 reference

1 November 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800830

1 November 2017

0 references

cites work

Breast cancer metastasis to the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

Brain metastases from breast cancer: identification of a high-risk group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

CNS metastases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Central nervous system metastases in breast cancer patients administered trastuzumab

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

HER2 and central nervous system metastasis in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Change of HER-2/neu status in a subset of distant metastases from breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Effects of antigen retrieval by microwave heating in formalin-fixed tissue sections on a broad panel of antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Standardised fluorescence in situ hybridisation in cytological and histological specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Stability of HER-2/neu expression over time and at multiple metastatic sites

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800830

7 January 2021

10.1038/MODPATHOL.3800830

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference